Mirum Pharmaceuticals, Inc. MIRM Accrued interest
Accrued interest at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPayableCurrent.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s accrued interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s accrued interest?
- Mirum Pharmaceuticals, Inc. (MIRM) reported accrued interest of $5.27M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s accrued interest changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s accrued interest decreased by 0.0% year-over-year, from $5.27M to $5.27M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s accrued interest?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s accrued interest has grown at a 0.0% compound annual growth rate (CAGR), from $2.11M to $2.11M.
- What does accrued interest mean?
- Interest expense accrued but not yet paid on outstanding debt obligations, based on contractual interest rates and time elapsed.